---
figid: PMC3208056__nihms311981f4
figtitle: Combination of atorvastatin with sulindac or naproxen profoundly inhibits
  colonic adenocarcinomas by suppressing the p65/Beta-catenin/cyclin D1 signaling
  pathway in rats
organisms:
- Mus musculus
- Rattus norvegicus
- Triticum aestivum
- Camellia sinensis
- Homo sapiens
pmcid: PMC3208056
filename: nihms311981f4.jpg
figlink: /pmc/articles/PMC3208056/figure/F4/
number: F4
caption: APC gene or activating mutations in β-catenin, result in the accumulation
  of β-catenin and subsequent complex formation with TCF/LEF transcription factors.
  Excessive β-catenin can interact with TCF to activate transcription of proliferating
  genes, such as c-Myc and cyclin D1, in the colon. Inflammatory cytokines activate
  NF-κB by releasing p65, which is then translocalized to the nucleus, leading to
  increased transcription of target genes, such as iNOS, COX-2, TNF-α interleukins,
  and cyclin D1. Atorvastatin, in combination with sulindac or naproxen, targets the
  NF-κB and βcatenin/Wnt pathways and inhibits downstream signaling, iNOS, COX-2,
  cyclin D1 and others.
papertitle: Combination of atorvastatin with sulindac or naproxen profoundly inhibits
  colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway
  in rats.
reftext: Nanjoo Suh, et al. Cancer Prev Res (Phila). ;4(11):1895-1902.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.932645
figid_alias: PMC3208056__F4
figtype: Figure
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Mus musculus
redirect_from: /figures/PMC3208056__F4
ndex: db6d1412-df09-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3208056__nihms311981f4.html
  '@type': Dataset
  description: APC gene or activating mutations in β-catenin, result in the accumulation
    of β-catenin and subsequent complex formation with TCF/LEF transcription factors.
    Excessive β-catenin can interact with TCF to activate transcription of proliferating
    genes, such as c-Myc and cyclin D1, in the colon. Inflammatory cytokines activate
    NF-κB by releasing p65, which is then translocalized to the nucleus, leading to
    increased transcription of target genes, such as iNOS, COX-2, TNF-α interleukins,
    and cyclin D1. Atorvastatin, in combination with sulindac or naproxen, targets
    the NF-κB and βcatenin/Wnt pathways and inhibits downstream signaling, iNOS, COX-2,
    cyclin D1 and others.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CTNNB1
  - APC
  - PROC
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - NFKB1
  - TNF
  - NOS2
  - ISYNA1
  - COX2
  - PTGS2
  - MTCO2P12
  - BCL2
  - MYC
  - HNF4A
  - RPSA
  - LRP1
  - PTPRA
  - MVP
  - Wnt2
  - Ctnnb1
  - Apc
  - Syt1
  - Nfkb1
  - Tnf
  - Nos2
  - Ptgs2
  - Bcl2
  - Myc
  - Ptpra
  - Cdc37
  - Lsp1
  - Pold2
  - Cd40
  - Dctn2
  - Rela
  - Gorasp1
  - Nol3
  - Lrp1
  - Mvp
  - Txlng
  - naproxen
  - sulindac
  - Cancer
---
